吴春霞,胡嘉锡,宋振华

衰弱综合征（Frailty Syndrome，FS）是影响老年人生活质量的重要临床综合征，其核心病理机制是肌肉疏松，同时抗应激能力下降，导致跌倒、残疾、住院和死亡率增加。本研究探讨了健脾活血中药结合艾灸治疗老年衰弱综合征的临床疗效。研究纳入了 2023 年 8 月至 2024 年 7 月期间在济南市第五人民医院老年病门诊和治疗区就诊的 25 名衰弱综合征患者，并使用 FRAIL 量表和 SARC-F 量表进行了评估。治疗方案包括口服健脾活血中药和穴位艾灸，每天一次，连续 14 天。对治疗前后的量表评分进行统计分析，以评估疗效。研究结果显示，治疗后 FRAIL 量表评分由 4.44±0.71 降至 3.80±0.65 (P<0.001)，SARC-F 量表评分由 6.80±1.44 降至 5.56±1.23 (P<0.001)，说明患者的衰弱程度和肌肉疏松状况均有不同程度的改善。该研究初步验证了健脾活血中药联合艾灸治疗老年衰弱综合征的临床价值，为衰弱综合征的防治提供了新思路。

衰弱综合征；艾灸；中医药疗法；健脾活血方剂

[1] CHEN X, MAO G, LENG S X. Frailty syndrome: an overview [J]. Clin Interv Aging, 2014, 9: 433-41. [2] WALSTON J, HADLEY E C, FERRUCCI L, et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults [J]. J Am Geriatr Soc, 2006, 54(6): 991-1001. [3] ANGULO J, EL ASSAR M, RODRíGUEZ-MAñAS L. Frailty and sarcopenia as the basis for the phenotypic manifestation of chronic diseases in older adults [J]. Mol Aspects Med, 2016, 50: 1-32. [4] CHANDOO A, CHI C H, JI W, et al. Gait speed predicts post-operative medical complications in elderly gastric cancer patients undergoing gastrectomy [J]. ANZ J Surg, 2018, 88(7-8): 723-6. [5] ROMERO-ORTUNO R, FORSYTH D R, WILSON K J, et al. The Association of Geriatric Syndromes with Hospital Outcomes [J]. J Hosp Med, 2017, 12(2): 83-9. [6] HOPMAN P, DE BRUIN S R, FORJAZ M J, et al. Effectiveness of comprehensive care programs for patients with multiple chronic conditions or frailty: A systematic literature review [J]. Health Policy, 2016, 120(7): 818-32. [7] HE L, GAO J, XIANG Y, et al. Effectiveness Evaluation of Jianpiyishenyaoshancijizhou for the Improvement of Frailty and Nutritional Status in Community-dwelling Frail Elderly Patients [J]. Chinese General Practice, 2018, 21(31): 3863. [8] XIU-FANG H, XIAO-FANG T, XUE-FENG Z, et al. The Investigation of Clinical Efficacy and Safety on BupiYishen Prescription in Elderly Frailty Patients [J]. 中华全科医学, 2019, 17(4): 653-6. [9] OP HET VELD L P M, AMENT B H L, VAN ROSSUM E, et al. Can resources moderate the impact of levels of frailty on adverse outcomes among (pre-) frail older people? A longitudinal study [J]. BMC Geriatr, 2017, 17(1): 185. [10] PANDEY A, KITZMAN D, REEVES G. Frailty Is Intertwined With Heart Failure: Mechanisms, Prevalence, Prognosis, Assessment, and Management [J]. JACC Heart Fail, 2019, 7(12): 1001-11. [11] ASSAR M E, LAOSA O, RODRíGUEZ MAñAS L. Diabetes and frailty [J]. Curr Opin Clin Nutr Metab Care, 2019, 22(1): 52-7. [12] TRENDELENBURG A U, SCHEUREN A C, POTTER P, et al. Geroprotectors: A role in the treatment of frailty [J]. Mechanisms of Ageing and Development, 2019, 180: 11-20. [13] DELAIRE L, COURTAY A, HUMBLOT J, et al. Implementation and Core Components of a Multimodal Program including Exercise and Nutrition in Prevention and Treatment of Frailty in Community-Dwelling Older Adults: A Narrative Review [J]. Nutrients, 2023, 15(19). [14] LOSA-REYNA J, BALTASAR-FERNANDEZ I, ALCAZAR J, et al. Effect of a short multicomponent exercise intervention focused on muscle power in frail and pre frail elderly: A pilot trial [J]. Exp Gerontol, 2019, 115: 114-21. [15] JIAO Y, WANG X, WANG Q, et al. Mechanisms by which kidney-tonifying Chinese herbs inhibit osteoclastogenesis: Emphasis on immune cells [J]. Front Pharmacol, 2023, 14: 1077796. [16] OGAWA-OCHIAI K, KAWASAKI K. Panax ginseng for Frailty-Related Disorders: A Review [J]. Front Nutr, 2018, 5: 140. [17] ZHENG C S, XU X J, YE H Z, et al. Computational pharmacological comparison of Salvia miltiorrhiza and Panax notoginseng used in the therapy of cardiovascular diseases [J]. Exp Ther Med, 2013, 6(5): 1163-8. [18] A R, YUE R, CHEN B, et al. Moxibustion for the treatment of Alzheimer's disease: A protocol for a systematic reviews and meta-analysis [J]. Medicine (Baltimore), 2021, 100(6): e24657.

点击下载PDF